If you made any changes in Pure these will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 23 Similar Profiles
Hematopoietic Stem Cell Transplantation Medicine & Life Sciences
Acute Myeloid Leukemia Medicine & Life Sciences
Stem Cell Transplantation Medicine & Life Sciences
Hematopoietic Stem Cells Medicine & Life Sciences
Peripheral Blood Stem Cell Transplantation Medicine & Life Sciences
Graft vs Host Disease Medicine & Life Sciences
Multiple Myeloma Medicine & Life Sciences
Transplantation Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1994 2019

1 Citation (Scopus)

A phase II study of lenalidomide consolidation and maintenance therapy after autologous PBSCT in patients with multiple myeloma

on behalf of the Japan Study Group for Cell Therapy and Transplantation (JSCT), Jan 22 2019, In : International journal of hematology. 109, 1, p. 107-114 8 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Peripheral Blood Stem Cell Transplantation
Dexamethasone
Therapeutics
lenalidomide

Bortezomib-based strategy with autologous stem cell transplantation for newly diagnosed multiple myeloma: a phase II study by the Japan Study Group for Cell Therapy and Transplantation (JSCT-MM12)

Sunami, K., Matsumoto, M., Fuchida, S. I., Omoto, E., Takamatsu, H., Adachi, Y., Choi, I., Fujishima, N., Kiguchi, T., Miyamoto, T., Maeda, A., Suzumiya, J., Yamamura, R., Nagafuji, K., Nakazato, T., Kuroda, Y., Yujiri, T., Takamatsu, Y., Harada, M. & Akashi, K., Jan 1 2019, In : International Journal of Clinical Oncology.

Research output: Contribution to journalArticle

Cell Transplantation
Stem Cell Transplantation
Group Psychotherapy
Cell- and Tissue-Based Therapy
Multiple Myeloma
Phase II Clinical Trials
Clinical Trials, Phase I
Systemic Scleroderma
Hematopoietic Stem Cell Transplantation
Japan

Clinical Implications of t(11;14) in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation

Takamatsu, H., Yamashita, T., Kurahashi, S., Saitoh, T., Kondo, T., Maeda, T., Nakazawa, H., Murata, M., Narita, T., Kuroda, J., Hashimoto, H., Kawamura, K., Miyamoto, T., Honda, S., Ichinohe, T., Atsuta, Y. & Sunami, K., Mar 1 2019, In : Biology of Blood and Marrow Transplantation. 25, 3, p. 474-479 6 p.

Research output: Contribution to journalArticle

Stem Cell Transplantation
Multiple Myeloma
Chromosome Aberrations
Melphalan
Survival
Hematology
Multiple Myeloma
Fees and Charges
Pharmaceutical Preparations
Organized Financing